Zobrazeno 1 - 10
of 689
pro vyhledávání: '"Mauricette Michallet"'
Autor:
Amine Belhabri, Mael Heiblig, Stephane Morisset, Liliana Vila, Clémence Santana, Emmanuelle Nicolas‐Virelizier, Sandrine Hayette, Isabelle Tigaud, Adriana Plesa, Hélène Labussiere‐Wallet, Mohamad Sobh, Anne‐Sophie Michallet, Balsat Marie, Franck‐Emmanuel Nicolini, Yann Guillermin, Fossard Gaëlle, Laure Lebras, Philippe Rey, Lucie Jauffret‐Bertholon, Marie‐Charlotte Laude, Loron Sandrine, Mauricette Michallet
Publikováno v:
Cancer Medicine, Vol 12, Iss 16, Pp 16929-16944 (2023)
Abstract Background t‐AML occurs after a primary malignancy treatment and retains a poor prognosis. Aims To determine the impact of primary malignancies, therapeutic strategies, and prognostic factors on clinical outcomes of t‐AML. Results A tota
Externí odkaz:
https://doaj.org/article/5ada555af80042d89c8cd782e7628bd6
Autor:
Louise Laloi, Natacha Chaumard Billotey, Pierre‐Yves Dumas, Franciane Paul, Alban Villate, Célestine Simand, Luc Fornecker, Florent Puisset, Sarah Bertoli, Marion Boissard Simonet, Kamel Laribi, Dyhia Houyou, Alberto Santagostino, Claire Michel, Gabrielle Roth Guepin, Elodie Guerineau, Reza Tabrizi, Mathilde Hunault, Aurélien Giltat, Eléonore Kaphan, Claude Bulabois, Elodie Cartet, Clément Rocher, Florence Lachenal, Stéphane Morisset, Christian Récher, Arnaud Pigneux, Amine Belhabri, Mauricette Michallet, Anne‐Sophie Michallet
Publikováno v:
Cancer Medicine, Vol 12, Iss 6, Pp 7175-7181 (2023)
Abstract Background Recently, the combination of venetoclax plus a hypomethylating agent (HMA; azacitidine ordecitabine) or low‐dose cytarabine (LDAC) showed promise in Phase III trials in previously untreated AML. In France at the time of this stu
Externí odkaz:
https://doaj.org/article/63f3a6ecd43b4f86b0b0537085a06afc
Autor:
Mauricette Michallet, Jean El Cheikh, Raoul Herbrecht, Ibrahim Yakoub-Agha, Denis Caillot, Jean-Pierre Gangneux
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Invasive fungal diseases (IFD) remain a major complication of allogeneic hematopoietic stem cell transplantation (alloHSCT) and are associated with high mortality rates in patients receiving alloHSCT. Antifungal prophylaxis is inc
Externí odkaz:
https://doaj.org/article/0fba3801708b4beaafd323235e12dae5
Autor:
Mohamed Amine Bekadja, Mauricette Michallet, Brahim Benzineb, Naima Mesli, Hafida Ouldjeriouat, Faiza Serradj, Mohamed Brahimi, Nabil Yafour
Publikováno v:
Asian Pacific Journal of Cancer Biology, Vol 6, Iss 4, Pp 249-254 (2021)
Introduction: Acute myeloid leukemia (AML) is a hematological malignancy with a poor prognosis. The early consequences of induction chemotherapy are represented by pancytopenia with severe immunosuppression, which favors the emergence of so-called
Externí odkaz:
https://doaj.org/article/a5a4738fa9f7474d9e56a39eb4bdc657
Autor:
Florent Malard, Anne Vekhoff, Simona Lapusan, Francoise Isnard, Evelyne D’incan-Corda, Jérôme Rey, Colombe Saillard, Xavier Thomas, Sophie Ducastelle-Lepretre, Etienne Paubelle, Marie-Virginie Larcher, Clément Rocher, Christian Recher, Suzanne Tavitian, Sarah Bertoli, Anne-Sophie Michallet, Lila Gilis, Pierre Peterlin, Patrice Chevallier, Stéphanie Nguyen, Emilie Plantamura, Lilia Boucinha, Cyrielle Gasc, Mauricette Michallet, Joel Dore, Ollivier Legrand, Mohamad Mohty
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
The combination of chemotherapy and broad-spectrum antibiotics induces gut microbiota (GM) dysbiosis in acute myeloid leukaemia (AML) leading to additional complications. Here, the authors report the efficacy in GM restoration and safety of autologou
Externí odkaz:
https://doaj.org/article/f0565b9c6bfc48c0b52d42791181b41c
Autor:
Xavier Poiré, Myriam Labopin, Emmanuelle Polge, Edouard Forcade, Arnold Ganser, Liisa Volin, Mauricette Michallet, Didier Blaise, Ibrahim Yakoub-Agha, Johan Maertens, Carlos Richard Espiga, Jan Cornelissen, Jürgen Finke, Mohamad Mohty, Jordi Esteve, Arnon Nagler
Publikováno v:
Haematologica, Vol 105, Iss 2 (2020)
Deletion 5q or monosomy 5 (-5/5q-) in acute myeloid leukemia (AML) is a common high-risk feature that is referred to allogeneic stem cell transplantation. However, -5/5q- is frequently associated with other high-risk cytogenetic aberrations such as c
Externí odkaz:
https://doaj.org/article/c77c56fab63c4c84bf3fde39bec3f148
Autor:
Lidia Delrieu, Liacine Bouaoun, Douae El Fatouhi, Elise Dumas, Anne-Deborah Bouhnik, Hugo Noelle, Emmanuelle Jacquet, Anne-Sophie Hamy, Florence Coussy, Fabien Reyal, Pierre-Etienne Heudel, Marc-Karim Bendiane, Baptiste Fournier, Mauricette Michallet, Béatrice Fervers, Guy Fagherazzi, Olivia Pérol
Publikováno v:
Cancers, Vol 13, Iss 5, p 1161 (2021)
Breast cancer (BC) remains complex for women both physically and psychologically. The objectives of this study were to (1) assess the evolution of the main sequelae and treatment two and five years after diagnosis in women with early-stage breast can
Externí odkaz:
https://doaj.org/article/e87bdfaa76b1493b847f626bc15ac6c8
Autor:
Annalisa Ruggeri, Giorgia Battipaglia, Myriam Labopin, Gerhard Ehninger, Dietrich Beelen, Johanna Tischer, Arnold Ganser, Rainer Schwerdtfeger, Bertram Glass, Jurgen Finke, Mauricette Michallet, Matthias Stelljes, Pavel Jindra, Renate Arnold, Nicolaus Kröger, Mohamad Mohty, Arnon Nagler
Publikováno v:
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-8 (2016)
Abstract Background Allogeneic stem cell transplantation is the only curative option for patients with acute myeloid leukemia (AML) experiencing relapse. Either matched sibling donor (MSD) or unrelated donor (UD) is indicated. Methods We analyzed 155
Externí odkaz:
https://doaj.org/article/e5135234ac2140389d8a22aad0b4fb06
Autor:
Jean-Pierre Gangneux, Christophe Padoin, Mauricette Michallet, Emeline Saillio, Alexandra Kumichel, Régis Peffault de La Tour, Patrice Ceballos, Thomas Gastinne, Arnaud Pigneux
Publikováno v:
Journal of Fungi, Vol 6, Iss 4, p 281 (2020)
Antifungal prophylaxis (AFP) is recommended by international guidelines for patients with acute myeloid leukaemia (AML) undergoing induction chemotherapy and allogeneic hematopoietic cell transplantation. Nonetheless, treatment of breakthrough fungal
Externí odkaz:
https://doaj.org/article/0b3b8f92ae4047d9b6376c5595fc49e1
Autor:
Ilhem Rahal, Claire Galambrun, Yves Bertrand, Nathalie Garnier, Catherine Paillard, Pierre Frange, Corinne Pondarré, Jean Hugues Dalle, Regis Peffault de Latour, Mauricette Michallet, Dominique Steschenko, Despina Moshous, Patrick Lutz, Jean Louis Stephan, Pierre Simon Rohrlich, Ibrahim Yakoub-Agha, Françoise Bernaudin, Christophe Piguet, Nathalie Aladjidi, Catherine Badens, Claire Berger, Gérard Socié, Cécile Dumesnil, Marie Pierre Castex, Marilyne Poirée, Anne Lambilliotte, Caroline Thomas, Pauline Simon, Pascal Auquier, Gérard Michel, Anderson Loundou, Imane Agouti, Isabelle Thuret
Publikováno v:
Haematologica, Vol 103, Iss 7 (2018)
In this retrospective study, we evaluate long-term complications in nearly all β-thalassemia-major patients who successfully received allogeneic hematopoietic stem cell transplantation in France. Ninety-nine patients were analyzed with a median age
Externí odkaz:
https://doaj.org/article/68ad5411bd59465d9e8ee8cdf3c285a6